Texas Rare Alliance

Our Founder & President, @khrystalkdavis took a strong position against PBMs in her op-ed calling for reform. Since PBMs emerged, patients face increasing barriers to access and pay more out of pocket for the medications they need. bit.ly/3Gsb3LK

Learn how the #PBM business model is misaligned between the interests of the #PBMs and the stakeholders they claim to serve. drugstorenews.com/reforming-pbm-…

There is an alarming shortage of some injectable drugs for #cancer and other life-threatening diseases, the result of misdirected government policies. It’s time for #340B reform. Put patients first. is.gd/Bwte7J

“Earlier this month, Grassley told Reuters the #PBM system was ‘an opaque operation. Transparency brings accountability, and there’s no accountability.’” is.gd/j0vFVu

Patient advocates are sharing their concerns with Congress on how the #340B program needs to be reformed. news.bloomberglaw.com/pharma-and-lif…

Tx faces significant lost therapies, innovation and 54,000+ #biopharma jobs under drug #pricecontrols bill from @RepRichardNeal @FrankPallone @repdavidscott. Bill would hurt patient access & care. More at: weworkforhealth.org/vital-transfor….

A group of US Senators is seeking information about how the #340B program can be reformed. More here: americanactionforum.org/weekly-checkup…

#PBM compensation and the list price of a medicine create an incentive for #PBMs to prefer higher list prices. Delinking this compensation arrangement could save an estimated $39.9 billion over a 10-year period. is.gd/KE21tN

A big thank you to our own Senator @JohnCornyn for joining with the 24 cosponsors of the #MCED Screening Coverage Act to create a pathway for early cancer detection for Texans on Medicare.

@JohnCornyn has joined 24 of his colleagues in cosponsoring the Medicare #MCED Screening Coverage Act, which will ensure America’s seniors will have timely access to early detection technologies. Thank you, Sen. Cornyn!

Patients should benefit from negotiated drug discounts. Right now, only #PBMs benefit – and this overcharging must stop. We urge @WaysMeansCmte @WaysandMeansGOP to fix this. Help patients save at the pharmacy counter with this #PBMreform.

Lean how the #340B program is potentially and unnecessarily encouraging the purchase of higher-priced prescription meds, which may inflate costs for patients. is.gd/qx1QhG

@JohnCornyn has joined 24 of his colleagues in cosponsoring the Medicare #MCED Screening Coverage Act, which will ensure America’s seniors will have timely access to early detection technologies. Thank you, Sen. Cornyn!

Drug discounts that benefit only #PBMs should be shared with patients. We hope this important #PBMreform is top of mind for @SenFinance members as they discuss #PBM accountability and PBM overcharging of patients. Thank you, Sen. @JohnCornyn for your attention to this issue.

Drug discounts that benefit only #PBMs should be shared with patients. We hope this important #PBMreform is top of mind for @SenFinance members as they discuss #PBM accountability and PBM overcharging of patients. Thank you, Sen. @JohnCronyn for your attention to this issue.

Stay up to date on the dozens of #PBM bills Congress is considering regarding #drugpricing and #PBMreform. natlawreview.com/article/pendin…

Learn why congressional oversight of the troubled #340B program is needed in order to help vulnerable patients. reuters.com/legal/litigati…

A bipartisan US Senate #340B working group wants to ensure the program is functioning as it should. healthleadersmedia.com/revenue-cycle/…

De-linking the compensation of #PBMs from a drug’s price is key to meaningful #PBMreform. Learn more here about the #PBMAct, which seeks to do just this. nbc16.com/news/local/leg…

Learn about the misaligned incentives regarding the role of #PBMs, the massive corporate middlemen in the drug supply chain. “Incentives” = profit-making opportunities for the largest PBMs. natlawreview.com/article/midyea…

.@VitalTransform study shows #GovernmentMandatedDrugPrices would result in 68% reduction in new FDA-approved medicines. Over 10 years, that equals 237 new therapies never making it to market. is.gd/Zctkrq